Back

Prevention of thromboembolism in COVID-19.

29 August 2021 (10:30 - 10:41)
Organised by:
Congress Presentation Part of: Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? Cardiovascular Disease in Specific Populations ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Antonio Martinez-Rubio

University Hospital of Sabadell, Sabadell (Spain)

4 More presentations in this session

Presentation thumbnail
COVID-19 myocarditis and myocardial injury: active participant or innocent bystander?
Professor G. Dan (Bucharest, RO)
Slides Video
Presentation thumbnail
Anti-inflammatory treatment of COVID-19 patients: which drugs and which patients?
Doctor A. Semb (Oslo, NO)
Slides Video
Presentation thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? – discussion.
Presentation thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? - Chat Moderator.

Access the full session

Session thumbnail
Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Preventive anticoagulation.
29 August 2022
thumbnail
Congress Session
Don’t forget to look right
18 May 2025
thumbnail
Congress Presentation
Thromboembolic events in the follow up of COVID-19 patients
29 June 2021
thumbnail
Congress Presentation
Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources